TAMBURELLO, Mariangela
 Distribuzione geografica
Continente #
NA - Nord America 1.484
AS - Asia 877
EU - Europa 543
SA - Sud America 110
AF - Africa 16
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.038
Nazione #
US - Stati Uniti d'America 1.457
SG - Singapore 290
IT - Italia 235
CN - Cina 232
BR - Brasile 88
HK - Hong Kong 69
FI - Finlandia 62
DE - Germania 59
VN - Vietnam 50
BD - Bangladesh 48
JP - Giappone 42
IN - India 32
FR - Francia 30
GB - Regno Unito 29
RU - Federazione Russa 20
TR - Turchia 19
AE - Emirati Arabi Uniti 16
CA - Canada 16
ID - Indonesia 16
NL - Olanda 16
SE - Svezia 16
PL - Polonia 15
KR - Corea 12
PK - Pakistan 11
CH - Svizzera 9
TW - Taiwan 9
AR - Argentina 8
ES - Italia 8
IE - Irlanda 8
BE - Belgio 7
PT - Portogallo 6
EG - Egitto 5
IQ - Iraq 5
MX - Messico 5
ZA - Sudafrica 5
AU - Australia 4
DZ - Algeria 4
EC - Ecuador 4
LT - Lituania 4
MY - Malesia 4
CL - Cile 3
CZ - Repubblica Ceca 3
NZ - Nuova Zelanda 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
CO - Colombia 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
UA - Ucraina 2
VE - Venezuela 2
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.038
Città #
Chicago 168
Singapore 165
Ashburn 106
San Jose 100
Los Angeles 94
Salt Lake City 77
Dallas 69
Hong Kong 63
New York 55
Brescia 41
Beijing 39
Tampa 38
Elk Grove Village 33
Helsinki 33
Council Bluffs 30
The Dalles 29
Buffalo 27
Milan 26
Tokyo 25
Sterling 22
Lauterbourg 21
Secaucus 20
Chandler 19
Lancaster 19
Des Moines 18
Shanghai 18
Ho Chi Minh City 17
Istanbul 17
Munich 16
Turku 16
West Jordan 16
Rome 14
Dubai 13
Hopkinton 13
Wilmington 11
Amsterdam 10
Dalmine 10
Bergamo 9
Boardman 9
Hanoi 9
Moscow 9
Santa Clara 9
Houston 8
Philadelphia 8
Stockholm 8
São Paulo 8
Bologna 7
Boston 7
Brooklyn 7
Brussels 7
Denver 7
Dulles 7
Düsseldorf 7
Hakozaki 7
Jakarta 7
Kansas City 7
Lappeenranta 7
Miami 7
Nuremberg 7
Orem 7
Atlanta 6
Calcinate 6
Charlotte 6
Memphis 6
Montreal 6
Mumbai 6
Naples 6
Princeton 6
Pune 6
Ruda Śląska 6
Seattle 6
Zurich 6
Ann Arbor 5
Augusta 5
Chennai 5
Detroit 5
Dublin 5
Fairfield 5
Hwaseong-si 5
Las Vegas 5
Redondo Beach 5
Rio de Janeiro 5
Romola 5
Semarang 5
Vancouver 5
Würzburg 5
Zhubei 5
Cagliari 4
Casalmaggiore 4
Da Nang 4
Frankfurt am Main 4
Haiphong 4
Islamabad 4
Kuala Lumpur 4
London 4
Palermo 4
Parma 4
Phoenix 4
Pittsburgh 4
Portsmouth 4
Totale 1.882
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 790
Carcinoma of the human adrenal cortex: identification and in vitro and in vivo study of molecular alterations as potential therapeutic targets 493
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 147
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 126
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 125
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 117
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 111
FSCN1 as a new druggable target in adrenocortical carcinoma 111
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 110
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 110
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 108
An update on adrenocortical cell lines of human origin 102
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma (ACC) Cell Lines, PDX, and Patient Samples 85
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 81
RETROSPECTIVE ANALYSIS OF THE PATIENT-REPORTED ADVERSE DRUG REACTIONS IN AN ITALIAN ALLERGY UNIT: ALLERG-RAF STUDY 76
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma 73
Cancer cell xenografts in zebrafish embryos as an experimental tool in drug screening for adrenocortical carcinoma 70
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 61
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 50
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 37
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 22
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models 20
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma 19
Primary Adrenal Malignancies 12
PPARG dysregulation as a potential molecular target in adrenal Cushing's syndrome 9
Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study 9
Updating ACC preclinical models: characterization of two new patient-derived cell lines 5
Totale 3.079
Categoria #
all - tutte 11.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/202257 8 3 2 3 3 3 8 0 2 11 5 9
2022/2023113 6 2 5 3 8 9 4 18 17 10 17 14
2023/2024335 18 13 18 30 32 41 25 52 34 33 13 26
2024/20251.212 30 26 16 106 44 28 38 32 102 44 242 504
2025/20261.356 90 130 102 119 124 108 192 75 97 143 102 74
Totale 3.079